These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 3926882)
1. Lymphokine-activated and natural killer cell activity in human intestinal mucosa. Hogan PG; Hapel AJ; Doe WF J Immunol; 1985 Sep; 135(3):1731-8. PubMed ID: 3926882 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic activity of intestinal lamina propria lymphocytes on human immunodeficiency virus (HIV)-infected cells. Di Massimo AM; Placido R; Bach S; Anastasi AM; Mastino A; Capobianchi MR; Colizzi V Immunology; 1992 May; 76(1):117-21. PubMed ID: 1628889 [TBL] [Abstract][Full Text] [Related]
3. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets. Ochoa AC; Hasz DE; Rezonzew R; Anderson PM; Bach FH Cancer Res; 1989 Feb; 49(4):963-8. PubMed ID: 2521457 [TBL] [Abstract][Full Text] [Related]
4. Lysis of human solid tumor cells by lymphokine-activated natural killer cells. Itoh K; Tilden AB; Balch CM J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648 [TBL] [Abstract][Full Text] [Related]
5. Generation of lymphokine-activated killer cell activity from human thymocytes. Ramsdell FJ; Golub SH J Immunol; 1987 Sep; 139(5):1446-53. PubMed ID: 2442246 [TBL] [Abstract][Full Text] [Related]
6. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells. Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622 [TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412 [TBL] [Abstract][Full Text] [Related]
8. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone. Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882 [TBL] [Abstract][Full Text] [Related]
9. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells. Tilden AB; Itoh K; Balch CM J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity. Gan X; Zhang L; Solomon GF; Bonavida B Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684 [TBL] [Abstract][Full Text] [Related]
11. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood. Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745 [TBL] [Abstract][Full Text] [Related]
12. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation. Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid. Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887 [TBL] [Abstract][Full Text] [Related]
14. [The cytotoxic activity in intestinal lamina propria and peripheral blood in AIDS and Crohn disease]. Fink CO; Raedler A; Voss A Z Gastroenterol; 1996 Feb; 34(2):111-5. PubMed ID: 8659185 [TBL] [Abstract][Full Text] [Related]
15. Lymphokine-activated killing by human intestinal lymphocytes. Ebert EC; Roberts AI Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783 [TBL] [Abstract][Full Text] [Related]
16. Human recombinant IL-4 suppresses the induction of human IL-2 induced lymphokine activated killer (LAK) activity. Brooks B; Rees RC Clin Exp Immunol; 1988 Nov; 74(2):162-5. PubMed ID: 3265652 [TBL] [Abstract][Full Text] [Related]
17. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells. Kasid A; Bell GI; Director EP J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414 [TBL] [Abstract][Full Text] [Related]
18. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues. Colquhoun SD; Economou JS; Shau H; Golub SH J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167 [TBL] [Abstract][Full Text] [Related]
19. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628 [TBL] [Abstract][Full Text] [Related]
20. Augmentation of lymphokine-activated killer cell cytotoxicity by monoclonal antibodies against human small cell lung carcinoma. Tong AW; Lee JC; Wang RM; Ordonez G; Stone MJ Cancer Res; 1989 Aug; 49(15):4103-8. PubMed ID: 2545333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]